XML 56 R37.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Total Stock-Based Compensation Expense Total stock-based compensation expense in our Consolidated Statements of Income during the twelve months ended December 31, 2024, 2023 and 2022 was as follows:
 Twelve Months Ended December 31,
202420232022
(In millions)
Cost of services$13.4 $14.5 $12.4 
Selling, general and administrative expenses68.2 57.3 50.2 
Stock-based compensation expense, before income taxes$81.6 $71.8 $62.6 
Assumptions Used to Estimate Fair Value of Stock Options Granted
The fair value for stock options granted during the twelve months ended December 31, 2024, 2023 and 2022 was estimated at the date of grant using the binomial model with the following weighted-average assumptions:
 Twelve Months Ended December 31,
 202420232022
Dividend yield0.8 %0.8 %0.7 %
Expected volatility31.9 %33.1 %31.5 %
Risk-free interest rate4.1 %3.9 %2.4 %
Expected term (in years)4.84.85.0
Weighted-average fair value of stock options granted$75.97$63.70$59.70
Changes in Outstanding Options and Weighed-Average Exercise Price Per Share
The following table summarizes changes in outstanding stock options during the twelve months ended December 31, 2024, as well as stock options that are vested and expected to vest and stock options exercisable at December 31, 2024: 
SharesWeighted-Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value
 (In thousands) (In years)(In millions)
Outstanding at December 31, 20231,961 $171.93   
Granted (all at market price)233 $253.10 
Exercised(665)$151.56 
Forfeited and canceled(132)$183.23 
Outstanding at December 31, 20241,397 $194.36 5.2$85.8 
Vested and expected to vest at December 31, 20241,386 $194.01 5.2$85.6 
Exercisable at December 31, 2024776 $162.29 3.9$71.9 
The following table summarizes changes in outstanding options and the related weighted-average exercise price per share for the twelve months ended December 31, 2023 and 2022:
 December 31,
 20232022
 Shares
Weighted-
Average Exercise Price
Shares
Weighted-
Average Exercise Price
 (In thousands)(In thousands)
Outstanding at the beginning of the year1,964 $164.72 1,710 $149.67 
Granted (all at market price)259 $210.37 369 $232.28 
Exercised(218)$143.98 (76)$136.84 
Forfeited and canceled(44)$205.81 (39)$198.34 
Outstanding at the end of the year1,961 $171.93 1,964 $164.72 
Exercisable at end of year1,326 $150.58 1,268 $141.40 
Summary of Changes in Nonvested Stock and Weighted-Average Grant Date Fair Value
The following table summarizes changes in these other stock awards during the twelve months ended December 31, 2024, 2023 and 2022 and the related weighted-average grant date fair value:
SharesWeighted-Average
Grant Date
Fair Value
 (In thousands) 
Nonvested at December 31, 2021779 $159.73 
Granted483 $196.97 
Vested(406)$133.26 
Forfeited(72)$202.70 
Nonvested at December 31, 2022784 $192.47 
Granted373 $205.98 
Vested(215)$172.62 
Forfeited(86)$194.11 
Nonvested at December 31, 2023856 $203.17 
Granted334 $250.64 
Vested(231)$178.51 
Forfeited(88)$217.04 
Nonvested at December 31, 2024871 $226.50